We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Scott Diehl

Scott R Diehl PhD

Professor, Oral Biology, Rutgers School of Dental Medicine; Professor, Health Informatics, Rutgers Biomedical Health Sciences, Rutgers, The State University of New Jersey, Newark, New Jersey

Dr Scott Diehl completed a Bachelor of Science (B.S.) degree from the State University of New York at Stony Brook (SUNY) with dual majors in Biology and Psychology. His doctoral research in genetics was performed at the University of Texas at Austin, followed by postdoctoral fellowships at the University of Massachusetts at Amherst and searching for the gene that causes neurofibromatosis as a Research Associate in the Department of Human Genetics at the University of Michigan in Ann Arbor. Dr Diehl next joined the faculty of the Medical College of Virginia from 1988 to 1993, performing research in Human Genetics and Psychiatry. From 1993-2002 he served as Chief of the Molecular Epidemiology and Disease Indicators Branch of the National Institute of Dental Research, and in other positions at the NIH. Since 2002, Dr Diehl has been teaching and conducting research as Professor of Oral Biology of Rutgers School of Dental Medicine, a part of Rutgers Biomedical Health Sciences (RBHS) of Rutgers University.

The focus of the Diehl Laboratory is to study Single Nucleotide Polymorphisms (SNPs) and other forms of variation in patients’ DNA to better understand the molecular causes of individual differences in disease susceptibility and in responses to drugs and other therapies. This "big data" research requires advanced computational systems, bioinformatics tools and databases. DNA variation is assayed using high-throughput microarrays and Next Generation Sequencing (NGS) technologies. High performance computing is necessary to perform the complex statistical genetic calculations on billions of data points required for this approach. Current research areas include genetic studies of trigeminal neuralgia and other forms of neuropathic pain, periodontitis, dental caries and head and neck cancers including nasopharyngeal carcinoma.

Recent Contributions to PracticeUpdate:

  1. Causal Association Between Periodontitis and Hypertension